SCHEMBL7876037

SCHEMBL7876037

Cc1[nH]c(=O)c(CC(c2ccc(F)c(F)c2)C2CC2)nc1CC(=O)NCCONC(=N)N

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 7/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876016 0.90 NOS1 (0.31)
SCHEMBL7867175 0.90 SLC6A2 (0.31)
SCHEMBL7872474 0.89 USP2 (0.34)
SCHEMBL7876222 0.85 OPRM1 (0.37)
SCHEMBL3241740 0.79 F2 (0.46)
SCHEMBL7876000 0.76 F2 (0.47)
Hydrochloric Acid SCHEMBL7867352 0.75 F2 (0.46)
SCHEMBL7867166 0.74 NOS1 (0.36)
SCHEMBL7874304 0.74
SCHEMBL7876040 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP claimed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO claimed
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP disclosed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO disclosed